SIGA Technologies (SIGA Technologies) Change In Receivables

: $24.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

SIGA Technologies's change in receivables for the quarter that ended in Dec. 2023 was $-13.1 Mil. It means SIGA Technologies's Accounts Receivable increased by $13.1 Mil from Sep. 2023 to Dec. 2023 .

SIGA Technologies's change in receivables for the fiscal year that ended in Dec. 2023 was $24.3 Mil. It means SIGA Technologies's Accounts Receivable declined by $24.3 Mil from Dec. 2022 to Dec. 2023 .

SIGA Technologies's Accounts Receivable for the quarter that ended in Dec. 2023 was $21.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. SIGA Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 16.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. SIGA Technologies's liquidation value for the three months ended in Dec. 2023 was $140.6 Mil.

SIGA Technologies Change In Receivables Historical Data

The historical data trend for SIGA Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SIGA Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

-2.21

0.83

-80.31

38.24

24.28

SIGA Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables																9.52	33.09	6.29	-2.02	-13.08

SIGA Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.3 Mil.

SIGA Technologies (NAS:SIGA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

SIGA Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	21.131	/	116.481	*	91
=	16.55

2. In Ben Graham's calculation of liquidation value, SIGA Technologies's accounts receivable are only considered to be worth 75% of book value:

SIGA Technologies's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	150.146	-	57.494	+	0.75 * 21.131	+	0.5 * 64.218
=	140.6

SIGA Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of SIGA Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SIGA Technologies (SIGA Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SIGA Technologies Inc (NAS:SIGA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

31 East 62nd Street, New York, NY, USA, 10065

Website

http://www.siga.com

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus.

Executives

Evan A. Knisely	director	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Jay Varma	director	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Ford Harold Eugene Jr.	director	4921 WILLIAM ARNOLD ROAD, MEMPHIS TN 38117
James Antal	director	30952 STEEPLECHASE DRIVE, SAN JUAN CAPISTRANO CA 92675
Holly L. Phillips	director	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Gary J. Nabel	director	C/O SIGA TECHNOLOGIES, INC., 31 EAST 62ND STREET, NEW YORK NY 10065
Julian Nemirovsky	director	35 EAST 62ND STREET, NEW YORK NY 10065
Edward P. Taibi	director	35 EAST 62ND STREET, NEW YORK NY 10065
Jaymie A Durnan	director	C/O SIGA TECHNOLOGIES, INC.,, 31 EAST 62ND STREET, NEW YORK NY 10065
Gomez Phillip Louis Iii	officer: Chief Executive Officer	7220 VAN NESS COURT, MCLEAN VA 22101
Daniel J Luckshire	officer: Executive VP & CFO	C/O SIGA TECHNOLOGIES, INC., 35 EAST 62ND STREET, NEW YORK NY 10065
Paul G Savas	director	35 EAST 62ND STREET, NEW YORK NY 10021
Julie Kane	director	77 BEALE ST, P.O. BOX 770000, SAN FRANCISCO CA 94177
Dennis E Hruby	officer: Chief Scientific Officer	SIGA TECHNOLOGIES, INC., 420 LEXINGTON AVENUE, SUITE 601, NEW YORK NY 10170
Michael J Bayer	director	1100 N GLEBE ROAD, ARLINGTON VA 22201